This work describes the role of NAFDAC in the regulation of clinical trials in Nigeria.
Clinical trials are experiments or observation done in clinical research. Such prospective biomedical or behavioural research studies on human participants are designed to answer specific questions about biomedical or behavioural interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements and medical devices) and known interventions that warrant further study and comparison. Only 10 percent of all drugs started in human clinical trials become an approved drug.
Ligali, F. (2018). CLINICAL TRIAL REGULATION IN NIGERIA AND NAFDAC. Afribary. Retrieved from https://track.afribary.com/works/clinical-trial-regulation-in-nigeria-and-nafdac
Ligali, Folakemi "CLINICAL TRIAL REGULATION IN NIGERIA AND NAFDAC" Afribary. Afribary, 14 Aug. 2018, https://track.afribary.com/works/clinical-trial-regulation-in-nigeria-and-nafdac. Accessed 24 Dec. 2024.
Ligali, Folakemi . "CLINICAL TRIAL REGULATION IN NIGERIA AND NAFDAC". Afribary, Afribary, 14 Aug. 2018. Web. 24 Dec. 2024. < https://track.afribary.com/works/clinical-trial-regulation-in-nigeria-and-nafdac >.
Ligali, Folakemi . "CLINICAL TRIAL REGULATION IN NIGERIA AND NAFDAC" Afribary (2018). Accessed December 24, 2024. https://track.afribary.com/works/clinical-trial-regulation-in-nigeria-and-nafdac